Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Neptune Wellness Solutions Inc. (NEPTF) vs Redhill Biopharma Ltd. (RDHL)

Neptune Wellness Solutions Inc. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $3.2M against $1.6M — 2.0× the size. Neptune Wellness Solutions Inc. grew revenue faster over the last twelve months: −24.8% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −135.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Redhill Biopharma Ltd. leads on 8 and Neptune Wellness Solutions Inc. on 7.

Valuation

Metric NEPTF RDHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 0.32 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 1.06 0.30 2.56
Earnings yield 0.00% (122,133.34%) (2.99%)
Free cash flow yield 0.00% (909.75%) 0.00%

Profitability

Metric NEPTF RDHL Drug Manufacturers Specialty & Generic median
Gross margin (1.94%) 35.16% 53.94%
Operating margin (190.39%) 0.00% 0.00%
Net margin (135.24%) 25.20% 0.00%
Free cash flow margin (40.57%) 0.00% 0.00%
Return on equity 291.47% 0.00% (0.40%)
Return on assets (121.62%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NEPTF RDHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (24.78%) (61.93%) 10.01%
EPS growth (last fiscal year) 67.05% 97.91% —
Revenue growth, 5-year CAGR 19.52% (66.15%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEPTF RDHL Drug Manufacturers Specialty & Generic median
Debt to equity (0.50) 0.00 0.05
Current ratio 0.23 0.56 2.31
Net debt to EBITDA (0.21) 0.53 0.85

Dividend

Metric NEPTF RDHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NEPTF RDHL Drug Manufacturers Specialty & Generic median
Market cap 1.60m 3.22m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack